MICROCHIP TECHNOLOGY INC
For the period ended Jun 30, 2025. Filed Aug 7, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Aug 7, 2025
MCHP$60.33-1.9%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows –
| Three Months Ended June 30, | ||
|---|---|---|
| 2025 | 2024 | |
| Cash flows from operating activities: | ||
| Net (loss) income | $(18.6) | $129.3 |
| Adjustments to reconcile net (loss) income to net cash provided by operating activities: | ||
| Depreciation and amortization | 171.1 | 188.7 |
| Deferred income taxes | (3.0) | (8.1) |
| Share-based compensation expense related to equity incentive plans | 52.9 | 44.0 |
| Amortization of debt discount | 1.4 | 16.6 |
| Amortization of debt issuance costs | 1.4 | 2.0 |
| Impairment of intangible assets | 2.2 | — |
| Other | (0.6) | (18.4) |
| Changes in operating assets and liabilities, excluding impact of acquisitions: | ||
| (Increase) decrease in accounts receivable | (75.8) | 47.9 |
| Decrease in inventories | 125.0 | 9.2 |
| Increase (decrease) in accounts payable and accrued liabilities | 27.6 | (41.2) |
| Change in other assets and liabilities | (3.4) | (20.7) |
| Change in income tax payable | (4.6) | 27.8 |
| Net cash provided by operating activities | 275.6 | 377.1 |
| Cash flows from investing activities: | ||
| Proceeds from capital-related government incentives | 4.8 | 0.1 |
| Investments in other assets | (23.8) | (52.7) |
| Capital expenditures | (17.9) | (72.9) |
| Net cash used in investing activities | (36.9) | (125.5) |
| Cash flows from financing activities: | ||
| Proceeds from issuance of Commercial Paper | — | 3,573.4 |
| Repayments of Commercial Paper | (174.1) | (4,637.5) |
| Proceeds from issuance of convertible debt | — | 1,250.0 |
| Deferred financing costs | — | (15.6) |
| Purchase of capped call options | — | (105.0) |
| Proceeds from sale of common stock | 12.4 | 13.1 |
| Tax payments related to shares withheld for vested RSUs | (8.4) | (18.9) |
| Repurchase of common stock | — | (72.7) |
| Payment of cash dividends on Series A Preferred Stock | (25.1) | — |
| Payment of cash dividends on common stock | (245.5) | (242.6) |
| Capital lease payments | (0.4) | (0.4) |
| Other Financing | (2.8) | — |
| Net cash used in financing activities | (443.9) | (256.2) |
| Net decrease in cash and cash equivalents | (205.2) | (4.6) |
| Cash and cash equivalents, at beginning of period | 771.7 | 319.7 |
| Cash and cash equivalents, at end of period | $566.5 | $315.1 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.